XML 79 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Financial Instruments and Derivatives
3 Months Ended
Mar. 31, 2013
Financial Instruments and Derivatives

D. Financial Instruments and Derivatives

Financial Instruments

Teradyne uses the market and income approach to value its financial instruments and there was no change in valuation techniques used by Teradyne during the three months ended March 31, 2013 and April 1, 2012. As defined in ASC 820-10, “Fair Value Measurements and Disclosures,” fair value is the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants. ASC 820-10 requires that assets and liabilities are carried at fair value and are classified in one of the following three categories:

Level 1: Quoted prices in active markets for identical assets as of the reporting date.

Level 2: Inputs other than Level 1, that are observable either directly or indirectly as of the reporting date. For example, a common approach for valuing fixed income securities is the use of matrix pricing. Matrix pricing is a mathematical technique used to value securities by relying on the securities’ relationship to other benchmark quoted prices.

Level 3: Unobservable inputs that are not supported by market data. Unobservable inputs are developed based on the best information available, which might include Teradyne’s own data.

Most of Teradyne’s fixed income securities are classified as Level 2, with the exception of U.S. Treasury securities and investments in equity and debt mutual funds, which are classified as Level 1, and contingent consideration, which is classified as Level 3. The majority of Level 2 securities are priced by third party pricing vendors. These pricing vendors utilize the most recent observable market information in pricing these securities or, if specific prices are not available, use other observable inputs like market transactions involving identical or comparable securities.

There were no realized losses recorded in the three months ended March 31, 2013 and April 1, 2012. Realized gains recorded in the three months ended March 31, 2013 and April 1, 2012 were $0.3 million and $0.3 million, respectively. Realized gains are included in interest income.

During the three months ended March 31, 2013 and April 1, 2012, there were no transfers in or out of Level 1, Level 2 or Level 3 financial instruments.

 

The following table sets forth by fair value hierarchy Teradyne’s financial assets and liabilities that were measured at fair value on a recurring basis as of March 31, 2013 and December 31, 2012.

 

     March 31, 2013  
     Quoted Prices
in Active
Markets for
Identical
Instruments
(Level  1)
     Significant
Other
Observable
Inputs
(Level 2)
     Significant
Unobservable
Inputs
(Level 3)
     Total  
     (in thousands)  

Assets

           

Cash

   $ 118,176       $ —        $ —        $ 118,176   

Cash equivalents

     179,798         7,245         —          187,043   

Available-for-sale securities:

           

U.S. Treasury securities

     315,107         —          —          315,107   

U.S. government agency securities

     —          211,341         —          211,341   

Commercial paper

     —          65,349         —          65,349   

Corporate debt securities

     —          47,704         —          47,704   

Equity and debt mutual funds

     11,189                —          11,189   

Certificates of deposit and time deposits

     —          259         —          259   

Non-U.S. government securities

     —          85         —          85   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 624,270       $ 331,983       $ —         $ 956,253   
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

           

Contingent consideration

   $ —        $ —        $ 75       $ 75   

Derivatives

     —          475         —          475   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ —        $ 475       $ 75       $ 550   
  

 

 

    

 

 

    

 

 

    

 

 

 

Reported as follows:

 

      (Level 1)      (Level 2)      (Level 3)      Total  
     (in thousands)  

Assets

           

Cash and cash equivalents

   $ 297,974       $ 7,245       $  —        $ 305,219   

Marketable securities

     232,452         172,329         —          404,781   

Long-term marketable securities

     93,844         152,409         —          246,253   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 624,270       $ 331,983       $  —        $ 956,253   
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

           

Other accrued liabilities

   $ —        $ 475       $ 75       $ 550   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ —        $ 475       $ 75       $ 550   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

    December 31, 2012  
    Quoted Prices
in Active
Markets for
Identical
Instruments
(Level 1)
    Significant
Other
Observable
Inputs
(Level 2)
    Significant
Unobservable
Inputs
(Level 3)
    Total  
    (in thousands)  

Assets

       

Cash

  $ 139,354      $ —       $  —       $ 139,354   

Cash equivalents

    183,039        16,527        —         199,566   

Available-for-sale securities:

       

U.S. Treasury securities

    312,116        —         —         312,116   

U.S. government agency securities

    —         217,655        —         217,655   

Commercial paper

    —         70,434        —         70,434   

Corporate debt securities

    —         55,755        —         55,755   

Equity and debt mutual funds

    9,717        —         —         9,717   

Certificates of deposit and time deposits

    —         1,627        —         1,627   

Non-U.S. government securities

    —         84        —         84   
 

 

 

   

 

 

   

 

 

   

 

 

 

Total

    644,226        362,082        —         1,006,308   

Derivatives

    —         121        —         121   
 

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 644,226      $ 362,203      $  —       $ 1,006,429   
 

 

 

   

 

 

   

 

 

   

 

 

 

Liabilities

       

Contingent consideration

  $ —       $ —       $ 388      $ 388   
 

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ —       $ —       $ 388      $ 388   
 

 

 

   

 

 

   

 

 

   

 

 

 

Reported as follows:

 

     (Level 1)      (Level 2)        (Level 3)     Total  
     (in thousands)  

Assets

            

Cash and cash equivalents

   $ 322,393       $ 16,527         $  —       $ 338,920   

Marketable securities

     239,192         192,324           —         431,516   

Long-term marketable securities

     82,641         153,231           —         235,872   

Prepayments and other current assets

     —          121           —         121   
  

 

 

    

 

 

      

 

 

   

 

 

 
   $ 644,226       $ 362,203         $  —       $ 1,006,429   
  

 

 

    

 

 

      

 

 

   

 

 

 

Liabilities

            

Other accrued liabilities

   $ —        $ —          $ 388      $ 388   
  

 

 

    

 

 

      

 

 

   

 

 

 
   $ —        $ —          $ 388      $ 388   
  

 

 

    

 

 

      

 

 

   

 

 

 

 

Changes in the fair value of Level 3 contingent consideration for the three months ended March 31, 2013 were as follows:

 

     Contingent consideration  
     (in thousands)  

Balance at December 31, 2012

   $ 388   

Payments

     (313
  

 

 

 

Balance at March 31, 2013

   $ 75   
  

 

 

 

The carrying amounts and fair values of financial instruments at March 31, 2013 and December 31, 2012 were as follows:

 

     March 31, 2013      December 31, 2012  
     Carrying Value      Fair Value      Carrying Value      Fair Value  
     (in thousands)  

Cash and cash equivalents

   $ 305,219       $ 305,219       $ 338,920       $ 338,920   

Marketable securities

     651,034         651,034         667,388         667,388   

Convertible debt(1)

     173,648         564,294         169,896         589,000   

Japan loan

     3,187         3,187         3,491         3,491   

 

(1) The carrying value represents the bifurcated debt component only, while the fair value is based on quoted market prices for the convertible note which includes the equity conversion feature.

The fair values of cash and cash equivalents, accounts receivable, net and accounts payable approximate the carrying amount due to the short-term maturities of these instruments.

The following tables summarize the composition of available-for-sale marketable securities at March 31, 2013 and December 31, 2012:

 

     March 31, 2013  
     Available-for-Sale      Fair Market
Value of
Investments
with  Unrealized
Losses
 
     Cost      Unrealized
Gain
     Unrealized
(Loss)
    Fair Market
Value
    
     (in thousands)  

U.S. Treasury securities

   $ 314,902       $ 231       $ (26   $ 315,107       $ 2,827   

U.S. government agency securities

     211,108         235         (2     211,341         8,013   

Commercial paper

     65,341         13         (5     65,349         15,484   

Corporate debt securities

     45,867         1,937         (100     47,704         16,307   

Equity and debt mutual funds

     9,626         1,577         (14     11,189         726   

Certificates of deposit and time deposits

     259         —          —         259         —    

Non-U.S. government securities

     85         —          —         85         —    
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 
   $ 647,188       $ 3,993       $ (147   $ 651,034       $ 43,357   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

 

Reported as follows:

 

     Cost      Unrealized
Gain
     Unrealized
(Loss)
    Fair Market
Value
     Fair Market
Value of
Investments
with Unrealized
Losses
 
     (in thousands)  

Marketable securities

   $ 404,576       $ 212       $ (7   $ 404,781       $ 23,651   

Long-term marketable securities

     242,612         3,781         (140     246,253         19,706   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 
   $ 647,l88       $ 3,993       $ (147   $ 651,034       $ 43,357   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

 

     December 31, 2012  
     Available-for-Sale      Fair Market
Value of
Investments
with  Unrealized
Losses
 
     Cost      Unrealized
Gain
     Unrealized
(Loss)
    Fair Market
Value
    
     (in thousands)  

U.S. Treasury securities

   $ 311,915       $ 216       $ (15   $ 312,116       $ 1,018   

U.S. government agency securities

     217,396         262         (3   $ 217,655         9,018   

Commercial paper

     70,431         9         (6     70,434         25,209   

Corporate debt securities

     53,405         2,414         (64     55,755         23,255   

Equity and debt mutual funds

     8,767         961         (11     9,717         600   

Certificates of deposit and time deposits

     1,627         —          —         1,627         —    

Non-U.S. government securities

     84         —          —         84         —    
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 
   $ 663,625       $ 3,862       $ (99   $ 667,388       $ 59,100   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Reported as follows:

 

     Cost      Unrealized
Gain
     Unrealized
(Loss)
    Fair Market
Value
     Fair Market
Value of
Investments
with Unrealized
Losses
 
     (in thousands)  

Marketable securities

   $ 431,324       $ 203       $ (11   $ 431,516       $ 41,110   

Long-term marketable securities

     232,301         3,659         (88     235,872         17,990   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 
   $ 663,625       $ 3,862       $ (99   $ 667,388       $ 59,100   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

As of March 31, 2013, the fair market value of marketable securities with unrealized losses totaled $43.4 million. Of this value, $0.3 million had unrealized losses greater than one year and $43.1 million had unrealized losses less than one year. As of December 31, 2012, the fair market value of marketable securities with unrealized losses totaled $59.1 million. There were no unrealized losses greater than one year.

The contractual maturities of available-for-sale marketable securities at March 31, 2013 were as follows:

 

     March 31, 2013  
     Cost      Fair Market
Value
 
     (in thousands)  

Due within one year

   $ 404,576       $ 404,781   

Due after 1 year through 5 years

     221,440         223,236   

Due after 5 years through 10 years

     2,684         2,895   

Due after 10 years

     18,488         20,122   
  

 

 

    

 

 

 

Total

   $ 647,188       $ 651,034   
  

 

 

    

 

 

 

 

Derivatives

Teradyne conducts business in a number of foreign countries, with certain transactions denominated in local currencies. The purpose of Teradyne’s foreign currency management is to minimize the effect of exchange rate fluctuations on certain foreign currency denominated net monetary assets. Teradyne does not use derivative financial instruments for trading or speculative purposes.

To minimize the effect of exchange rate fluctuations associated with the remeasurement of monetary assets and liabilities denominated in foreign currencies, Teradyne enters into foreign currency forward contracts. The change in fair value of these derivatives is recorded directly in earnings, and is used to offset the change in fair value of the monetary assets and liabilities denominated in foreign currencies.

The notional amount of foreign exchange contracts hedging monetary assets and liabilities denominated in foreign currencies was $69.0 million and $64.1 million at March 31, 2013 and December 31, 2012, respectively.

The following table summarizes the fair value of derivative instruments at March 31, 2013 and December 31, 2012.

 

     Balance Sheet Location    March 31,
2013
     December 31,
2012
 
          (in thousands)  

Derivatives not designated as hedging instruments:

        

Foreign exchange contracts

   Prepayments and other current assets    $  —         $ 121   

Foreign exchange contracts

   Other accrued liabilities      475         —     
     

 

 

    

 

 

 
      $ 475       $ 121   
     

 

 

    

 

 

 

Teradyne had no offsetting foreign exchange contracts at March 31, 2013 and December 31, 2012.

The following table summarizes the effect of derivative instruments recognized in the statement of operations during the three months ended March 31, 2013 and April 1, 2012. The table does not reflect the corresponding gains (losses) from the remeasurement of the monetary assets and liabilities denominated in foreign currencies.

 

     Location of Gains
Recognized in Statement
of Operations
     For the Three Months
Ended
 
      March 31,
2013
     April 1,
2012
 
            (in thousands)  

Derivatives not designated as hedging instruments:

        

Foreign exchange contracts

     Interest expense and other       $ 2,248       $ 2,880  
     

 

 

    

 

 

 
      $ 2,248       $ 2,880   
     

 

 

    

 

 

 

See Note E “Debt” regarding derivatives related to convertible senior notes.